GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Preferred Dividends

Boundless Bio (Boundless Bio) Preferred Dividends : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Boundless Bio's preferred dividends for the three months ended in Dec. 2023 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Boundless Bio Preferred Dividends Historical Data

The historical data trend for Boundless Bio's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio Preferred Dividends Chart

Boundless Bio Annual Data
Trend Dec21 Dec22 Dec23
Preferred Dividends
- - -

Boundless Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Preferred Dividends Get a 7-Day Free Trial - - - - -

Boundless Bio Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Boundless Bio  (NAS:BOLD) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boundless Bio (Boundless Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Preferred Dividends
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://www.boundlessbio.com
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Boundless Bio (Boundless Bio) Headlines

From GuruFocus

Boundless Bio Announces Pricing of Initial Public Offering

By Business Wire • 03-27-2024